Explore the pivotal role of the Moonshot Cancer Initiative and MCED Consortium in shaping the landscape of early cancer detection and screening, with a focus on innovative screening tools and legislative support.
Melanoma In Darker Skin Tones: Race and Sex Play A Role, Mayo Study Finds
Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa
EV-302 Trial Ushers in Era of Novel Combos in First-Line Metastatic Urothelial Cancer
FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL
AML, ALL, and Glioblastoma Multiforme Clinical Trials Seek to Push the Needle Forward
Acalabrutinib Yields Long-Term Efficacy in a Pooled Analysis of Higher-Risk CLL
Dr Liu Previews ASCO 2024 Lung Cancer Data
Dr Rajkumar Previews ASCO 2024 Data in Multiple Myeloma
Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer